Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
- Products
-
- clomiPRAMINE hydrochloride Capsules USP
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
USA nationwide
Nationwide
- Units affected
- 2724 bottles
- About this recall
- clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01